Advertisement

Impact of Left Ventricular Global Longitudinal Strain on Outcomes After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation

Published:September 06, 2022DOI:https://doi.org/10.1016/j.amjcard.2022.07.023
      Assessment of left ventricular (LV) systolic function is essential in patient selection for transcatheter edge-to-edge repair (TEER) in secondary mitral regurgitation (MR). Although LV ejection fraction (EF) is mostly used for assessing LV function, it represents the change of LV chamber size, but not myocardial contractility. LV global longitudinal strain (GLS) provides an alternative to assess LV systolic function in patients with secondary MR. This study included 380 patients with secondary MR (mean age 71.0 ± 13.0 years; 61.1% male) who underwent TEER. Patients were dichotomized based on baseline LV GLS (more impaired GLS [<7.0%] vs less impaired GLS [≥7%]) based on existing literature. The primary outcome was all-cause mortality, whereas the secondary outcome was the composite end point of all-cause mortality and heart failure hospitalization. The mean LV GLS was 8.1 ± 3.8%, and 162 patients had GLS <7%. Patients with more impaired GLS (<7%) were more likely to be male (68.5% vs 55.5%; p = 0.01) and have larger LV end-diastolic volume (110.5 ± 36.5 ml/m2 vs 92.9 ± 34.3 ml/m2; p <0.001) and lower LVEF (22.2 ± 8.9% vs 36.4 ± 14.5%; p <0.001) than those with less impaired GLS (≥7%). The number of clips used and residual MR were similar between the 2 groups. Patients with more impaired LV GLS (<7%) had significantly higher 2-year event rates of the primary outcome (38.2% vs 25.9%; log-rank p = 0.003) and the secondary outcome (52.5% vs 36.3%; log-rank p <0.001). Multivariate analysis showed that LV GLS (<7%) was independently associated with the primary outcome (hazard ratio 1.65, 95% confidence interval 1.16 to 2.34, p = 0.005) and the secondary outcome (hazard ratio 1.54, 95% confidence interval 1.08 to 2.20, p = 0.016) whereas such associations were not observed with LVEF. In conclusion, LV GLS (<7%) was independently associated with a higher risk of adverse events in patients with secondary MR who underwent TEER.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nkomo VT
        • Gardin JM
        • Skelton TN
        • Gottdiener JS
        • Scott CG
        • Enriquez-Sarano M.
        Burden of valvular heart diseases: a population-based study.
        Lancet. 2006; 368: 1005-1011
        • Dziadzko V
        • Dziadzko M
        • Medina-Inojosa JR
        • Benfari G
        • Michelena HI
        • Crestanello JA
        • Maalouf J
        • Thapa P
        • Enriquez-Sarano M.
        Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome.
        Eur Heart J. 2019; 40: 2194-2202
        • Sannino A
        • Smith 2nd, RL
        • Schiattarella GG
        • Trimarco B
        • Esposito G
        • Grayburn PA
        Survival and cardiovascular outcomes of patients with secondary mitral regurgitation: a systematic review and meta-analysis.
        JAMA Cardiol. 2017; 2: 1130-1139
        • Stone GW
        • Lindenfeld J
        • Abraham WT
        • Kar S
        • Lim DS
        • Mishell JM
        • Whisenant B
        • Grayburn PA
        • Rinaldi M
        • Kapadia SR
        • Rajagopal V
        • Sarembock IJ
        • Brieke A
        • Marx SO
        • Cohen DJ
        • Weissman NJ
        • Mack MJ
        • Investigators COAPT
        Transcatheter mitral-valve repair in patients with heart failure.
        N Engl J Med. 2018; 379: 2307-2318
        • Obadia JF
        • Messika-Zeitoun D
        • Leurent G
        • Lung B
        • Bonnet G
        • Piriou N
        • Lefèvre T
        • Piot C
        • Rouleau F
        • Carrié D
        • Nejjari M
        • Ohlmann P
        • Leclercq F
        • Saint Etienne C
        • Teiger E
        • Leroux L
        • Karam N
        • Michel N
        • Gilard M
        • Donal E
        • Trochu JN
        • Cormier B
        • Armoiry X
        • Boutitie F
        • Maucort-Boulch D
        • Barnel C
        • Samson G
        • Guerin P
        • Vahanian A
        • Mewton N
        • MITRA-FR Investigators
        Percutaneous repair or medical treatment for secondary mitral regurgitation.
        N Engl J Med. 2018; 379: 2297-2306
        • Pibarot P
        • Delgado V
        • vs Bax JJ.MITRA-FR
        COAPT: lessons from two trials with diametrically opposed results.
        Eur Heart J Cardiovasc Imaging. 2019; 20: 620-624
        • Otto CM
        • Nishimura RA
        • Bonow RO
        • Carabello BA
        • Erwin 3rd, JP
        • Gentile F
        • Jneid H
        • Krieger EV
        • Mack M
        • McLeod C
        • O'Gara PT
        • Rigolin VH
        • Sundt 3rd, TM
        • Thompson A
        • Toly C
        • Writing Committee Members
        2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
        J Am Coll Cardiol. 2021; 77 (Published correction appears in J Am Coll Cardiol 2021;77:509. Published correction appears in J Am Coll Cardiol 2021;77:1275): e25-e197
        • Lang RM
        • Badano LP
        • Mor-Avi V
        • Afilalo J
        • Armstrong A
        • Ernande L
        • Flachskampf FA
        • Foster E
        • Goldstein SA
        • Kuznetsova T
        • Lancellotti P
        • Muraru D
        • Picard MH
        • Rietzschel ER
        • Rudski L
        • Spencer KT
        • Tsang W
        • Voigt JU.
        Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
        J Am Soc Echocardiogr. 2015; 28: 1-39.e14
        • Mitchell C
        • Rahko PS
        • Blauwet LA
        • Canaday B
        • Finstuen JA
        • Foster MC
        • Horton K
        • Ogunyankin KO
        • Palma RA
        • Velazquez EJ.
        Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography.
        J Am Soc Echocardiogr. 2019; 32: 1-64
        • Zoghbi WA
        • Adams D
        • Bonow RO
        • Enriquez-Sarano M
        • Foster E
        • Grayburn PA
        • Hahn RT
        • Han Y
        • Hung J
        • Lang RM
        • Little SH
        • Shah DJ
        • Shernan S
        • Thavendiranathan P
        • Thomas JD
        • Weissman NJ.
        Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance.
        J Am Soc Echocardiogr. 2017; 30: 303-371
        • Zoghbi WA
        • Asch FM
        • Bruce C
        • Gillam LD
        • Grayburn PA
        • Hahn RT
        • Inglessis I
        • Islam AM
        • Lerakis S
        • Little SH
        • Siegel RJ
        • Skubas N
        • Slesnick TC
        • Stewart WJ
        • Thavendiranathan P
        • Weissman NJ
        • Yasukochi S
        • Zimmerman KG.
        Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance.
        J Am Soc Echocardiogr. 2019; 32 (Published correction appears in J Am Soc Echocardiogr 2019;32:914–917): 431-475
        • Grayburn PA
        • Carabello B
        • Hung J
        • Gillam LD
        • Liang D
        • Mack MJ
        • McCarthy PM
        • Miller DC
        • Trento A
        • Siegel RJ.
        Defining “severe” secondary mitral regurgitation: emphasizing an integrated approach.
        J Am Coll Cardiol. 2014; 64: 2792-2801
        • Lancellotti P
        • Tribouilloy C
        • Hagendorff A
        • Popescu BA
        • Edvardsen T
        • Pierard LA
        • Badano L
        • Zamorano JL
        Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging.
        Eur Heart J Cardiovasc Imaging. 2013; 14: 611-644
        • Cavalcante JL
        • Rodriguez LL
        • Kapadia S
        • Tuzcu EM
        • Stewart WJ.
        Role of echocardiography in percutaneous mitral valve interventions.
        JACC Cardiovasc Imaging. 2012; 5: 733-746
        • Rudski LG
        • Lai WW
        • Afilalo J
        • Hua L
        • Handschumacher MD
        • Chandrasekaran K
        • Solomon SD
        • Louie EK
        • Schiller NB.
        Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.
        J Am Soc Echocardiogr. 2010; 23 (quiz 786–788): 685-713
        • Namazi F
        • van der Bijl P
        • Hirasawa K
        • Kamperidis V
        • van Wijngaarden SE
        • Mertens B
        • Leon MB
        • Hahn RT
        • Stone GW
        • Narula J
        • Ajmone Marsan N
        • Delgado V
        • Bax JJ
        Prognostic value of left ventricular global longitudinal strain in patients with secondary mitral regurgitation.
        J Am Coll Cardiol. 2020; 75: 750-758
        • Stone GW
        • Adams DH
        • Abraham WT
        • Kappetein AP
        • Généreux P
        • Vranckx P
        • Mehran R
        • Kuck KH
        • Leon MB
        • Piazza N
        • Head SJ
        • Filippatos G
        • Vahanian AS
        • Mitral Valve Academic Research Consortium (MVARC)
        Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the Mitral Valve Academic Research Consortium.
        J Am Coll Cardiol. 2015; 66: 308-321
        • Shah AM
        • Claggett B
        • Sweitzer NK
        • Shah SJ
        • Anand IS
        • Liu L
        • Pitt B
        • Pfeffer MA
        • Solomon SD.
        Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone.
        Circulation. 2015; 132: 402-414
        • Kalam K
        • Otahal P
        • Marwick TH.
        Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction.
        Heart. 2014; 100: 1673-1680
        • Citro R
        • Baldi C
        • Lancellotti P
        • Silverio A
        • Provenza G
        • Bellino M
        • Di Muro MR
        • Mastrogiovanni G
        • De Rosa R
        • Galasso G
        • Bossone E
        • Giudice P
        • Piscione F.
        Global longitudinal strain predicts outcome after MitraClip implantation for secondary mitral regurgitation.
        J Cardiovasc Med (Hagerstown). 2017; 18: 669-678
        • Slimani A
        • Melchior J
        • de Meester C
        • Pierard S
        • Roy C
        • Amzulescu M
        • Bouzin C
        • Maes F
        • Pasquet A
        • Pouleur AC
        • Vancraeynest D
        • Gerber B
        • El Khoury G
        • Vanoverschelde JL
        Relative contribution of afterload and interstitial fibrosis to myocardial function in severe aortic stenosis.
        JACC Cardiovasc Imaging. 2020; 13: 589-600
        • Alashi A
        • Mentias A
        • Abdallah A
        • Feng K
        • Gillinov AM
        • Rodriguez LL
        • Johnston DR
        • Svensson LG
        • Popovic ZB
        • Griffin BP
        • Desai MY.
        Incremental prognostic utility of left ventricular global longitudinal strain in asymptomatic patients with significant chronic aortic regurgitation and preserved left ventricular ejection fraction.
        JACC Cardiovasc Imaging. 2018; 11: 673-682
        • Gaasch WH
        • Aurigemma GP
        • Meyer TE.
        An appraisal of the association of clinical outcomes with the severity of regurgitant volume relative to end-diastolic volume in patients with secondary mitral regurgitation.
        JAMA Cardiol. 2020; 5: 476-481